A detailed history of Capricorn Fund Managers LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Capricorn Fund Managers LTD holds 96,685 shares of EXAS stock, worth $6.48 Million. This represents 2.34% of its overall portfolio holdings.

Number of Shares
96,685
Holding current value
$6.48 Million
% of portfolio
2.34%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 21, 2026

BUY
$56.19 - $69.63 $5.43 Million - $6.73 Million
96,685 New
96,685 $6.48 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Capricorn Fund Managers LTD Portfolio

Follow Capricorn Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capricorn Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capricorn Fund Managers LTD with notifications on news.